Rheumatology · Red Bank, NJ
NPI
1750382800
Since 2005
Specialty
Rheumatology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
282 Broad St
Red Bank, NJ, 07701
Phone (732) 842-3600
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.5M
520,695 services
Medicare patients, 2024
898
Average age 74
Drug cost, 2024
$5.9M
8,557 prescriptions
Company payments, 2025
$175K
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard Haddad was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 203,600 times for 110 patients. In total Richard Haddad billed 520,695 services in 55 codes, and Medicare paid $5.5M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-10-22.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 203,600 | 110 | $3.55 | $723K |
| J3262 Injection, tocilizumab, 1 mg | Office | 144,400 | 63 | $4.70 | $678K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 65,490 | 112 | $9.04 | $592K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 32,950 | 73 | $33.40 | $1.1M |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 21,000 | 29 | $8.57 | $180K |
| J3247 Injection, secukinumab, intravenous, 1 mg | Office | 9,850 | 13 | $13.76 | $136K |
| J0490 Injection, belimumab, 10 mg | Office | 7,670 | 12 | $41.85 | $321K |
| J0897 Injection, denosumab, 1 mg | Office | 6,240 | 77 | $20.50 | $128K |
| J7329 Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | Office | 2,925 | 26 | $5.67 | $17K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 2,569 | 20 | $24.56 | $63K |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 1,575 | 328 | $5.46 | $8,602 |
| 96413 Chemotherapy Administration | Office | 1,537 | 261 | $116.75 | $179K |
| 96401 Chemotherapy Administration | Office | 1,047 | 113 | $65.40 | $68K |
| J3304 Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 992 | 16 | $13.77 | $14K |
| 96372 Injection Administration | Office | 966 | 320 | $12.65 | $12K |
By year: 2022 $4.0M for 492,632 services; 2023 $4.4M for 549,958 services; 2024 $5.5M for 520,695 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87426 Immunoassay | 14 | 11 | $34.62 | $485 |
Medicare prescription drug claims, 2024
In 2024, the drug Richard Haddad prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 1,175 prescriptions and refills. In total Richard Haddad wrote 8,557 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 1,175 | 2,394 | 355 | $24K |
| Prednisone Generic | 1,050 | 1,345 | 364 | $6,247 |
| Hydroxychloroquine Sulfate Generic | 891 | 1,586 | 239 | $34K |
| Gabapentin Generic | 544 | 859 | 131 | $5,901 |
| Allopurinol Generic | 393 | 882 | 98 | $4,133 |
| Duloxetine Hcl Generic | 321 | 660 | 89 | $6,088 |
| Meloxicam Generic | 221 | 373 | 82 | $989 |
| Simponi Aria Golimumab | 216 | 356 | 48 | $1.5M |
| Tramadol Hcl Generic | 196 | 205 | 43 | $1,629 |
| Sulfasalazine Generic | 191 | 353 | 62 | $3,639 |
| Celecoxib Generic | 183 | 340 | 66 | $3,979 |
| Methylprednisolone Generic | 177 | 202 | 119 | $1,644 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 173 | 173 | 25 | $4,657 |
| Folic Acid Generic | 144 | 371 | 52 | $1,439 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 136 | 136 | 21 | $3,106 |
Brand drugs: - claims; generic drugs: 7,524 claims; opioid claims: 607.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard Haddad $175K ($175K in general payments such as food, travel and fees) from 28 companies. The largest payer was Janssen Biotech, Inc. with $63K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 126 | $63K |
| Amgen Inc. AMGN | 83 | $39K |
| Abbvie Inc. ABBV | 66 | $28K |
| GlaxoSmithKline, LLC. GSK | 29 | $20K |
| UCB, Inc. UCB.BR | 20 | $6,557 |
| AstraZeneca Pharmaceuticals LP AZN | 25 | $6,546 |
| E.R. Squibb & Sons, L.L.C. BMY | 26 | $6,434 |
| Sobi, Inc SOBI.ST | 6 | $2,675 |
| Novartis Pharmaceuticals Corporation NVS | 24 | $414 |
| Mallinckrodt Hospital Products Inc. | 6 | $297 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.